- Home
- ACRV vs SPPP Comparison
ACRV vs SPPP Comparison
Compare ACRV & SPPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- SPPP
- Stock Information
- Founded
- ACRV 2018
- SPPP 2011
- Country
- ACRV United States
- SPPP Canada
- Employees
- ACRV N/A
- SPPP N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- SPPP
- Sector
- ACRV Health Care
- SPPP
- Exchange
- ACRV Nasdaq
- SPPP NYSE
- Market Cap
- ACRV 59.9M
- SPPP 172.2M
- IPO Year
- ACRV 2022
- SPPP N/A
- Fundamental
- Price
- ACRV $1.18
- SPPP $9.61
- Analyst Decision
- ACRV Strong Buy
- SPPP
- Analyst Count
- ACRV 5
- SPPP 0
- Target Price
- ACRV $19.75
- SPPP N/A
- AVG Volume (30 Days)
- ACRV 1.3M
- SPPP 183.3K
- Earning Date
- ACRV 05-13-2025
- SPPP 01-01-0001
- Dividend Yield
- ACRV N/A
- SPPP N/A
- EPS Growth
- ACRV N/A
- SPPP N/A
- EPS
- ACRV N/A
- SPPP N/A
- Revenue
- ACRV N/A
- SPPP N/A
- Revenue This Year
- ACRV N/A
- SPPP N/A
- Revenue Next Year
- ACRV N/A
- SPPP N/A
- P/E Ratio
- ACRV N/A
- SPPP N/A
- Revenue Growth
- ACRV N/A
- SPPP N/A
- 52 Week Low
- ACRV $1.30
- SPPP $8.55
- 52 Week High
- ACRV $10.29
- SPPP $11.39
- Technical
- Relative Strength Index (RSI)
- ACRV 29.23
- SPPP 55.15
- Support Level
- ACRV $1.32
- SPPP $9.50
- Resistance Level
- ACRV $1.50
- SPPP $9.51
- Average True Range (ATR)
- ACRV 0.19
- SPPP 0.10
- MACD
- ACRV 0.06
- SPPP 0.02
- Stochastic Oscillator
- ACRV 2.08
- SPPP 82.48
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.